An experimental drug from Bristol-Myers Squibb and Pfizer reduces the risk of stroke by more than half compared with aspirin, with no significant rise in major bleeding, researchers said on Tuesday.
An international scientific team has identified for the first time a genetic risk factor associated with common migraines and say their research could open the way for new treatments to prevent migraine attacks.
Cutting medicine prices and promoting cheap generics in the way European governments are now doing could jeopardize the long-term supply of new heart drugs, a top cardiologist said on Saturday.
A rare and dangerous reaction to a range of common medicines including antibiotics and anticonvulsants may be caused by a severe immune response to reactivated herpes virus, scientists said on Wednesday.
Australia's drug modulator has revealed 15 people have committed suicide and hundreds have experienced suicidal thoughts while on Champix - the popular smoking-cessation drug, since 2008.
Pfizer Inc
posted higher-than-expected quarterly results and stood by its longer-term profit view, allaying investor concern over looming generic drug competition and lifting its shares almost 6 percent.Sanofi-Aventis investors have urged the drugmaker not to pay more than about $19 billion to land Genzyme, some $10 a share below the price wanted by the U.S. biotech group.
Stocks slipped on Tuesday after disappointing results from Dow component Procter & Gamble and some discouraging economic data, but robust earnings from drug giant Pfizer limited the market's decline.
Pfizer Inc
posted higher-than-expected quarterly results and stood by its longer-term profit view, allaying investor concern over looming generic drug competition and lifting its shares 5 percent.Sanofi-Aventis chief Chris Viehbacher should avoid paying much more than about $70 per share, or a total of $19 billion, to land U.S. biotech group Genzyme, shareholders in the French group say.
Sanofi-Aventis sent a takeover proposal valued at about $18.4 billion, or $69 per share, to biotechnology company Genzyme Corp and the two sides are discussing the offer, sources familiar with the situation said on Monday.
Pfizer reported higher-than-expected quarterly earnings and revenue, and the world's biggest drugmaker said its full-year profit will be at the upper end of its prior view as savings continue to pile on from its recent merger with Wyeth.
Pfizer Inc reported higher-than-expected quarterly earnings and revenue, and the world's biggest drugmaker said its full-year profit will be at top end of its prior view as savings accrue from its recent merger with Wyeth.
Drugmakers Merck, Tibotec and Gilead are in advanced talks with UNITAID about a patent pool to make AIDS drugs more widely available to the poor, the health funding agency said on Wednesday.
Stock index futures dipped on Tuesday as investors took a more cautious view over China's vow of more yuan flexibility, while data on home sales was on tap later in the morning.
Stock index futures rose on Thursday, boosted by confirmation of solid China export data and a climb in the euro as investors awaited a report on the U.S. labor market.
(Reuters) - People using cholesterol-lowering statins have a higher risks of liver dysfunction, kidney failure, muscle weakness and cataracts and such side effects of the drug should be closely tracked, doctors said on Friday.
Drugmaker Pfizer Inc will cut 6,000 jobs, or 18 percent of the workforce, at its 78 manufacturing plants over the next five years as it pares back operations following last year's purchase of rival Wyeth.
Drugmaker Pfizer Inc will cut 6,000, or 18 percent, of jobs at its 78 manufacturing plants over the next five years as it consolidates operations following last year's purchase of smaller rival Wyeth.
U.S. drugmakers Pfizer Inc and Merck & Co Inc posted better-than-expected quarterly results, helped by cost savings from their respective mega-mergers that could boost results for several more years.
U.S. drugmakers Pfizer Inc and Merck & Co posted better-than-expected first-quarter profit and revenue on Tuesday, but Merck gave a 2010 earnings forecast that could fall short of Wall Street's target.
April's jobs report and a slew of other economic indicators may bolster U.S. stocks this week, but jitters over Greece's debt and investigations into Goldman Sachs will test the market's resiliency.
